Infinium™ Global Screening Array (GSA) v3.0 BeadChip
A powerful, high-quality, cost-effective array for population-scale genetic studies.
HIGHLIGHTS
- Greater than 650,000 SNP assays
- Optimized global content including SNP content utilizing a multi-ethnic genome wide approach, clinical research variants, and ability to add custom content.
- Broad clinical research applications that enables genotyping for complex disease studies, pharmacogenomics research, and lifestyle and wellness characterization.
- NEOGEN Genomics’ high throughput workflow enables processing thousands of samples per week for population-scale studies.
The Infinium Global Screening v3.0 BeadChip builds on the success of its consortium version that has been widely adopted human disease researchers, health care networks, and consumer genomics companies. The GSA BeadChip provides coverage of pharmacogenomics variants associated with absorption, distribution, metabolism, and excretion (ADME) phenotypes based on PharmGKB17 and Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines. The clinical research content of the Infinium Global Screening v3.0 BeadChip was designed through collaboration with medical genomics experts using multiple, widely utilized, annotation databases to create an informative, cost-effective panel for clinical research applications.
Contact genomicsinfo@NEOGEN.com or call 877.443.6489 for more information